期刊
CELL DEATH AND DIFFERENTIATION
卷 8, 期 9, 页码 899-908出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.cdd.4400885
关键词
cisplatin; protein kinase C; caspases; apoptosis; Cytochrome c
资金
- NCI NIH HHS [CA71727, CA85682] Funding Source: Medline
We have previously shown that the protein kinase C (PKC) signal transduction pathway regulates cell death by the DNA damaging agent cis-diamminedichloroplatinum(II) (cDDP). In the present study we have investigated how PKC influences the sequence of events that are triggered by cDDP-induced DNA damage. cDDP caused activation of caspases-8,-9,-3,-7 and cleavage of PKC delta. Rottlerin, a selective inhibitor of novel PKC delta, blocked activation of caspases, proteolytic activation of PKC delta and cell death induced by cDDP. In contrast, Go 6976, an inhibitor of conventional PKC alpha and betaI, did not prevent cDDP-induced caspase activation and cDDP cytotoxicity. In HeLa cells, PKC delta was distributed both in the cytosol and heavy membrane (HM) fraction containing mitochondria. While caspase-8 was primarily cytosolic, a small amount of caspases-9, -7 and -3 could be detected in the HM fraction. cDDP caused a time-dependent increase in Cytochrome c release from the mitochondria and processing of both cytosolic and membrane-associated caspases, as well as proteolytic cleavage of PKC delta. Rottlerin attenuated late but not early release of Cytochrome c by cDDP. It, however, inhibited activation of caspases and proteolytic cleavage of PKC delta in both cytosolic and HM fractions. The antiapoptotic effect of rottlerin was evident when it was added together with or following cDDP addition but not when added after cDDP was removed from the medium. Thus, the PKC delta inhibitor acts at an early stage of the cDDP-induced cell death pathway that precedes caspase activation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据